Home / Business and Economy / AI Digital Twins Revolutionize Healthcare
AI Digital Twins Revolutionize Healthcare
16 Mar
Summary
- AI digital twins aim to shift healthcare to predictive treatment planning.
- This technology enables personalized and minimally invasive interventions.
- Respiratory diseases like lung cancer and COPD show rising global trends.
AI-driven digital twin technologies are set to revolutionize healthcare by moving treatment planning from reactive imaging interpretation to proactive, simulation-driven strategies. This advancement is particularly relevant given the ongoing global increase in respiratory diseases, such as lung cancer and chronic obstructive pulmonary disease (COPD).
The development of these AI solutions by companies like LTTS aims to facilitate more personalized medical interventions and enable minimally invasive procedures. Such technologies are expected to create a significant shift in how diseases are managed and treated in the future.
While the focus is on future healthcare transformations, shares of LTTS recently saw a decline, closing 3.8% lower at 3,299 on the NSE. Year-to-date, the shares have experienced a negative return of 24.6%.
